Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.5%

2 terminated out of 31 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

19%

6 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results87% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (14)
Early P 1 (1)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed13
Recruiting7
Unknown5
Terminated2
Withdrawn2
Not Yet Recruiting1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT07272473Not ApplicableRecruitingPrimary

Effects of Cervical Mobilization on Dizziness, Balance, and Joint Position Sense in Patients With Meniere's Disease

NCT05960786Not ApplicableCompleted

Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand

NCT03795675Not ApplicableRecruiting

CI Following VS Removal or Labyrinthectomy

NCT04815187Phase 4Active Not RecruitingPrimary

Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease

NCT03520322Not ApplicableTerminatedPrimary

A Study of a Mastoid Device in Subjects With Ménière's Disease

NCT04766853Phase 1Completed

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

NCT05424302Not ApplicableRecruiting

Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy

NCT06544434Phase 2RecruitingPrimary

Laser Acupuncture for Meniere Disease

NCT06544590CompletedPrimary

Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease

NCT04677972Phase 3CompletedPrimary

SPI-1005 for the Treatment of Meniere's Disease

NCT04218123Phase 2CompletedPrimary

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

NCT04686695Not ApplicableCompletedPrimary

Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease

NCT04370366RecruitingPrimary

Imaging of Endolymphatic Hydrops at 7T MRI

NCT06278129Recruiting

Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease

NCT05851508Phase 3RecruitingPrimary

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease

NCT04794842Early Phase 1Unknown

Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection

NCT05844657CompletedPrimary

Comprehensive Evaluation in Patients With Meniere's Disease

NCT03664674Phase 3CompletedPrimary

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

NCT05328895Not ApplicableCompletedPrimary

Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease

NCT05582148Not ApplicableUnknownPrimary

Meniere Disease and Hearing Aids

Scroll to load more

Research Network

Activity Timeline